40 results
DEF 14A
ADCT
Adc Therapeutics SA
26 Apr 24
Definitive proxy
4:05pm
in achieving its operational and strategic goals and objectives, the NEO’s contribution to Company performance and, for our non-CEO NEOs … in achieving our strategic goals and his individual performance. The compensation of our other two NEOs, Mr. Carmona and Dr. Zaki, was considered by our
PRE 14A
ADCT
Adc Therapeutics SA
16 Apr 24
Preliminary proxy
4:16pm
overall performance and its success in achieving its operational and strategic goals and objectives, the NEO’s contribution to Company performance … of experience, the critical role he plays in achieving our strategic goals and his individual performance. The compensation of our other two NEOs, Mr. Carmona
8-K
EX-99.1
ADCT
Adc Therapeutics SA
9 Apr 24
3 Agenda ▪ Business Update ▪ Our Research Strategy ▪ Our Platform ▪ Lead Candidates ▪ Forward Looking ▪ Closing Remarks ▪ Q&A
4:06pm
Development Goals: U.S. EX - U.S. Co - development & Co - promote* Royalty & Milestones to ADCT Accelerate & Expand Asset Development 3 Non - dilutive
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
the submission is filed, the FDA begins an in-depth review of the BLA. Under the goals and policies agreed to by the FDA under PDUFA, the FDA has 10 months, from … perform periodic employee engagement surveys, set and monitor retention goals, and offer training and leadership development to cultivate our
8-K
EX-99.2
ADCT
Adc Therapeutics SA
13 Mar 24
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
7:39am
Business Development Goals: U.S. EX-U.S. Co‐development & Co‐promote* Royalty & Milestones to ADCT Accelerate & Expand Asset Development3 Non‐dilutive
8-K
EX-99.1
vgyjht 6zu
5 Mar 24
Regulation FD Disclosure
9:15am
8-K
EX-10.1
fdzqtcvvbmqxvk2n1ua
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.2
dnym5yq0fd1i7vpis
4 Jan 24
ADC Therapeutics Provides Business Updates
7:00am
S-8
EX-99.2
ptr t9u60d
4 Dec 23
Registration of securities for employees
4:57pm
S-8
EX-99.1
2cfnl fkueayt726odh
4 Dec 23
Registration of securities for employees
4:57pm
6-K
EX-99.4
i1dkhbvhok32hnd1h
17 Mar 22
Current report (foreign)
4:06pm
6-K
xb6x8bov
1 Jun 21
Current report (foreign)
4:42pm
S-8
EX-99.1
hc62zrh1p
6 May 21
Registration of securities for employees
4:21pm
6-K
EX-99.4
7rt3fvpoqmf ly
18 Mar 21
Current report (foreign)
4:16pm
20-F
l0dlq1x
18 Mar 21
Annual report (foreign)
7:12am
20-F
EX-4.6
761s1v0b1muht21iva
18 Mar 21
Annual report (foreign)
7:12am
20-F
EX-4.3
17jh 2yubi
18 Mar 21
Annual report (foreign)
7:12am
6-K
EX-99.1
nms34 xwe
18 Mar 21
ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Updates
7:05am